Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 6/2016

07.10.2015 | Original Article

Comparison of Efficacy of Granisetron and Promethazine in Control of Hyperemesis Gravidarum

verfasst von: Ashraf Aleyasin, Elham Saffarieh, Hassan Torkamandi, Somayeh Hanafi, Fariborz Sadeghi, Atossa Mahdavi, Fatemeh Bahmaei, Mohammadreza Javadi

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hyperemesis gravidarum is the third leading cause of hospitalization during pregnancy. 5-HT3-receptor antagonists are the most effective against chemotherapy-induced nausea and vomiting and radiation. This randomized study aimed to compare and evaluate the efficacies of granisetron and promethazine for controlling nausea and vomiting of pregnancy.

Methods

The included patients were administered (oral and intravenous) granisetron and promethazine randomly. The patients were evaluated for nausea and vomiting by a senior gynecology resident blinded to designated drugs.

Results

This study revealed that granisetron significantly decreased nausea and vomiting in pregnant women (p < 0.05). Greater patient satisfaction and lesser adverse drug reactions in women receiving granisetron observed in this study suggest that it can be introduced as a more effective and safer drug in comparison with promethazine.

Conclusions

Considering the prevalence of nausea and vomiting of pregnancy and hyperemesis gravidarum, we can state that it is a health-related problem with economic, social and psychological dimensions. All efforts especially simple outpatient strategies to reduce its severity will help the pregnant woman continue her pregnancy with more satisfaction.
Literatur
1.
Zurück zum Zitat Badell ML, Ramin SM, Smith JA. Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy. 2006;26(9):1273–87.CrossRefPubMed Badell ML, Ramin SM, Smith JA. Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy. 2006;26(9):1273–87.CrossRefPubMed
2.
Zurück zum Zitat Bottomley C, Bourne T. Management strategies for hyperemesis. Best Practice & Research Clinical Obstetrics and Gynaecology. 2009;23:549–64.CrossRef Bottomley C, Bourne T. Management strategies for hyperemesis. Best Practice & Research Clinical Obstetrics and Gynaecology. 2009;23:549–64.CrossRef
3.
Zurück zum Zitat Tan PC, Khine PP, Vallikkannu N, et al. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2010;115(5):975–81.CrossRefPubMed Tan PC, Khine PP, Vallikkannu N, et al. Promethazine compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2010;115(5):975–81.CrossRefPubMed
4.
Zurück zum Zitat Goodwin TM. Nausea and vomiting of pregnancy. OBG Manag. 2004;16:54–67. Goodwin TM. Nausea and vomiting of pregnancy. OBG Manag. 2004;16:54–67.
5.
Zurück zum Zitat Ebrahimi N, Maltepe C, Garcia Bournissen F, et al. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803–7.CrossRefPubMed Ebrahimi N, Maltepe C, Garcia Bournissen F, et al. Nausea and vomiting of pregnancy: using the 24-hour Pregnancy-Unique Quantification of Emesis (PUQE-24) scale. J Obstet Gynaecol Can. 2009;31(9):803–7.CrossRefPubMed
6.
Zurück zum Zitat Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010;17(5):476–86.CrossRefPubMed Hsu ES. A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics. Am J Ther. 2010;17(5):476–86.CrossRefPubMed
7.
Zurück zum Zitat Board T, Board R. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting. AORN J. 2006;83(1):209–20.CrossRefPubMed Board T, Board R. The role of 5-HT3 receptor antagonists in preventing postoperative nausea and vomiting. AORN J. 2006;83(1):209–20.CrossRefPubMed
8.
Zurück zum Zitat Einarson A, Maltepe C, Navioz Y, et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG. 2004;111(9):940–3.CrossRefPubMed Einarson A, Maltepe C, Navioz Y, et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG. 2004;111(9):940–3.CrossRefPubMed
9.
Zurück zum Zitat Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J. 1996;72(853):688–9.CrossRefPubMedPubMedCentral Tincello DG, Johnstone MJ. Treatment of hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Postgrad Med J. 1996;72(853):688–9.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Barrett TW, DiPersio DM, Jenkins CA, et al. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011;29:247–55.CrossRefPubMed Barrett TW, DiPersio DM, Jenkins CA, et al. A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. Am J Emerg Med. 2011;29:247–55.CrossRefPubMed
11.
Zurück zum Zitat Ferreira E, Gillet M, Lelièvre J, et al. Ondansetron use during pregnancy: a case series. J Popul Ther Clin Pharmacol. 2012;19(1):e1–10.PubMed Ferreira E, Gillet M, Lelièvre J, et al. Ondansetron use during pregnancy: a case series. J Popul Ther Clin Pharmacol. 2012;19(1):e1–10.PubMed
12.
Zurück zum Zitat Bhatnagar S, Gupta D, Mishra S, et al. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study. J Clin Anesth. 2007;19:512–6.CrossRefPubMed Bhatnagar S, Gupta D, Mishra S, et al. Preemptive antiemesis in patients undergoing modified radical mastectomy: oral granisetron versus oral ondansetron in a double-blind, randomized, controlled study. J Clin Anesth. 2007;19:512–6.CrossRefPubMed
13.
Zurück zum Zitat Contreras-Dominguez V, Carbonell-Bellolio P. Prophylactic antiemetic therapy for acute abdominal surgery. A comparative study of droperidol, metoclopramide, tropisetron, granisetron and dexamethasone. Rev Bras Anestesiol. 2008;58:35–44.CrossRefPubMed Contreras-Dominguez V, Carbonell-Bellolio P. Prophylactic antiemetic therapy for acute abdominal surgery. A comparative study of droperidol, metoclopramide, tropisetron, granisetron and dexamethasone. Rev Bras Anestesiol. 2008;58:35–44.CrossRefPubMed
14.
Zurück zum Zitat Gan TJ, Candiotti KA, Klein SM, et al. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anesth. 2009;56:829–36.CrossRefPubMed Gan TJ, Candiotti KA, Klein SM, et al. Double-blind comparison of granisetron, promethazine, or a combination of both for the prevention of postoperative nausea and vomiting in females undergoing outpatient laparoscopies. Can J Anesth. 2009;56:829–36.CrossRefPubMed
15.
Zurück zum Zitat McCarthy FP, Khashan AS, North RA. A Prospective Cohort study investigating associations between Hyperemesis Gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS One. 2011;6(11):e27678.CrossRefPubMedPubMedCentral McCarthy FP, Khashan AS, North RA. A Prospective Cohort study investigating associations between Hyperemesis Gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS One. 2011;6(11):e27678.CrossRefPubMedPubMedCentral
Metadaten
Titel
Comparison of Efficacy of Granisetron and Promethazine in Control of Hyperemesis Gravidarum
verfasst von
Ashraf Aleyasin
Elham Saffarieh
Hassan Torkamandi
Somayeh Hanafi
Fariborz Sadeghi
Atossa Mahdavi
Fatemeh Bahmaei
Mohammadreza Javadi
Publikationsdatum
07.10.2015
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 6/2016
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-015-0709-6

Weitere Artikel der Ausgabe 6/2016

The Journal of Obstetrics and Gynecology of India 6/2016 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.